ConductScience.org, home

Paper17569850

Immunology. The shape of things to come.

Fitzgerald KA and 1 other. Science, 2007. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Immunology. The shape of things to come. Papers, record 17569850. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17569850

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunology. The shape of things to come.
PubMed
Journal
Science
PubMed
Year
2007
PubMed
Publication types
Journal Article, Comment
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2026-01-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fitzgerald KAKatherine A
2Golenbock DTDouglas T

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
Lipid AMajor topic
Lymphocyte Antigen 96Major topic
Toll-Like Receptor 4Major topic
Adaptor Proteins, Signal Transducing
Adaptor Proteins, Vesicular Transport
Animals
Crystallography, X-Ray
Glycolipids
Humans
Hydrophobic and Hydrophilic Interactions
Ligands
Lymphocyte Activation
Mice
Phosphates
Protein Conformation
Receptors, Interleukin
Signal Transduction
T-Lymphocytes

Source PubMed

Download CSV of topics

Comments and corrections2

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment on17569868The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.https://conductscience.org/library/papers/17569868PubMed
Comment on17569869Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa.https://conductscience.org/library/papers/17569869PubMed

Download CSV of comments and corrections

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
23977276Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy.PLoS One2013https://conductscience.org/library/papers/23977276PubMed
22241978Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?PLoS Pathog2011https://conductscience.org/library/papers/22241978PubMed
20949109CpG-ODN and MPLA prevent mortality in a murine model of post-hemorrhage-Staphyloccocus aureus pneumonia.PLoS One2010https://conductscience.org/library/papers/20949109PubMed
20795687Escherichia coli mutants that synthesize dephosphorylated lipid A molecules.Biochemistry2010https://conductscience.org/library/papers/20795687PubMed
20673780Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.Mol Aspects Med2010https://conductscience.org/library/papers/20673780PubMed
18847302Personalized vaccines: the emerging field of vaccinomics.Expert Opin Biol Ther2008https://conductscience.org/library/papers/18847302PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17569850

GET https://conductscience.org/api/papers/v1/17569850/authors